Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: J Neurochem. 2009 May 3;110(1):363–377. doi: 10.1111/j.1471-4159.2009.06140.x

Table 1.

Spearman rank order r and p-values for relationships between the magnitude of sensitization (Day 7/Day 1), GluR1 S/l ratio, pERK2/ERK2, pCaMKII/CaMKII, pCaMKII/total protein, CaMKII/total protein and overall PKA substrate phosphorylation in saline (SAL), all cocaine-exposed (ALL), sensitized (SENS) and non-sensitized (NON) rats on WD1, WD7, and WD21

Day 7/Day 1
GluR1 S/1
pERK2/ERK2
pCAMKII/CaMKII
pCAMKII/total protein
Total CAMKII/
Total Protein
Measure SAL ALL SENS NON SAL ALL SENS NON SAL ALL SENS NON SAL ALL SENS NON SAL ALL SENS NON SAL ALL SENS NON
WD 1 GluFM S/l r –0.33 0.02 –0.26 0.89
p 0.33 0.94 0.66 0.00
pERK2/ERK2 r 0.26 0.06 0.14 0.60 –0.01 –0.63 –0.43 –0.68
p 0.42 0.81 0.80 0.08 0.97 0.02 0.42 0.07
pCAMKII/CaMKII r 0.13 0.59 –0.32 –0.38 –0.35 0.13 0.31 0.11 0.43 0.03 0.60 –0.43
p 0.67 0.02 0.44 0.32 0.31 0.67 0.56 0.78 0.18 0.90 0.24 0.26
Overall PKA r 0.36 –0.09 –0.32 –0.30 –0.42 0.23 –0.77 0.75 0.30 –0.21 0.09 –0.37 0.80 0.01 0.07 –0.10
p 0.27 0.74 0.44 0.41 0.21 0.44 0.10 0.04 0.35 0.45 0.92 0.31 0.00 0.95 0.84 0.79
WD 7 GluFM S/l r 0.47 0.58 0.60 –0.11
p 0.14 0.00 0.02 0.78
pERK2/ERK2 r 0.41 0.16 0.32 0.04 0.53 0.44 0.43 0.43
p 0.10 0.46 0.27 0.89 0.03 0.04 0.14 0.30
pCAMKII/CaMKII r 0.08 0.06 0.26 0.25 0.15 –0.11 –0.04 –0.14 –0.43 0.30 0.42 0.04
p 0.77 0.77 0.36 0.47 0.57 0.65 0.89 0.72 0.09 0.18 0.19 0.89
pCAMKII/total protein r –0.05 –0.01 –0.03 0.18 –0.24 –0.20 –0.21 –0.26 –0.04 –0.12 –0.05 –0.17
p 0.82 0.98 0.91 0.61 0.34 0.37 0.45 0.66 0.88 0.58 0.86 0.64
CaMKII/total protein r 0.02 –0.05 –0.18 0.03 –0.10 –0.13 –0.18 –0.26 0.47 –0.31 –0.35 –0.25
p 0.94 0.82 0.53 0.91 0.70 0.59 0.55 0.66 0.07 0.18 0.28 0.49
Overall PKA r –0.12 –0.25 –0.53 0.19 0.17 –0.41 –0.49 –0.11 0.14 0.43 –0.34 –0.50 0.39 0.13 0.05 0.20 0.14 0.55 0.58 0.45 0.15 0.43 0.50 0.42
p 0.62 0.25 0.06 0.58 0.48 0.08 0.10 0.78 0.58 0.05 0.30 0.13 0.12 0.55 0.87 0.56 0.58 0.01 0.04 0.20 0.57 0.05 0.09 0.24
WD 21 GluR1 S/l r –0.18 0.51 0.58 –0.01
p 0.46 0.00 0.01 0.97
pERK2/ERK2 r –0.23 0.36 0.36 0.36 0.62 –0.06 –0.39 –0.20
p 0.36 0.12 0.39 0.24 0.01 0.81 0.34 0.53
pCAMKII/CaMKII r –0.11 –0.06 0.15 –0.07 –0.06 0.47 0.67 –0.34 0.30 0.09 0.17 0.01
p 0.66 0.79 0.68 0.82 0.79 0.03 0.04 0.26 0.22 0.71 0.66 0.96
Overall PKA r –0.12 0.38 –0.32 0.22 –0.06 0.48 0.57 0.15 –0.28 0.28 –0.10 0.34 –0.10 0.64 0.75 0.57
p 0.62 0.08 0.35 0.48 0.80 0.03 0.10 0.62 0.26 0.23 0.79 0.27 0.69 0.00 0.01 0.04

Shaded boxes indicate statistically significant corrections.